Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 141–160 of 17,529 recalls

December 16, 2025· SpecGx, LLC

Recalled Item: Oxycodone and Acetaminophen CII Tablets USP

The Issue: Failed Tablet/Capsule Specification: There is a potential for

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 16, 2025· Alembic Pharmaceuticals Limited

Recalled Item: Fesoterodine Fumarate

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
December 15, 2025· StuffbyNainax

Recalled Item: MR. 7 SUPER 700000 capsules

The Issue: Undeclared Sildenafil

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
December 15, 2025· NOVADOZ PHARMACEUTICALS LLC

Recalled Item: Glycopyrrolate Oral Solution

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
December 12, 2025· Medinatura New Mexico, inc.

Recalled Item: ClearLife Allergy Nasal Spray

The Issue: Microbial Contamination of Non-Sterile Products: The products have

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
December 12, 2025· Medinatura New Mexico, inc.

Recalled Item: ReBoost Nasal Spray

The Issue: Microbial Contamination of Non-Sterile Products: The products have

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
December 12, 2025· Merck Sharp & Dohme LLC

Recalled Item: Merck Emend (aprepitant) for oral suspension

The Issue: Presence of particulate matter: potential presence of metal

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 12, 2025· Merck Sharp & Dohme LLC

Recalled Item: Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension

The Issue: Presence of particulate matter: potential presence of metal

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 9, 2025· SUN PHARMA /TARO

Recalled Item: Ciclopirox Shampoo

The Issue: Failed Impurity/Degradation specifications: OOS results obtained at the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 8, 2025· Signature Formulations, LLC

Recalled Item: ORL Kids Mouthwash

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 8, 2025· Signature Formulations, LLC

Recalled Item: ORL Kids Natural Toothpaste

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 26, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Clindamycin Phosphate USP

The Issue: Failed Impurities/Degradation: Out of Specification results for Total

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
November 26, 2025· Golden State Medical Supply Inc.

Recalled Item: Baclofen Tablets USP

The Issue: Presence of Foreign Tablets/Capsules

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 26, 2025· SOMERSET THERAPEUTICS LLC

Recalled Item: Cisatracurium Besylate Injection USP

The Issue: Subpotent product:out of specification assay results observed during

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
November 26, 2025· SOMERSET THERAPEUTICS LLC

Recalled Item: Cisatracurium Besylate Injection USP

The Issue: Subpotent product:out of specification assay results observed during

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
November 26, 2025· SOMERSET THERAPEUTICS LLC

Recalled Item: Cisatracurium Besylate Injection USP

The Issue: Subpotent product:out of specification assay results observed during

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
November 26, 2025· Winder Laboratories, LLC

Recalled Item: Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL)

The Issue: Correct Labeled Product Mispack-Size stated on carton label

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
November 24, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules

The Issue: CGMP Deviations; presence of N-nitroso-duloxetine impurity above the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 24, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules

The Issue: CGMP Deviations; presence of N-nitroso-duloxetine impurity above the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 21, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Bisoprolol Fumarate and Hydrochlorothiazide Tablets

The Issue: Cross Contamination with Other Products: Testing of reserve

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund